UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013223
Receipt number R000015432
Scientific Title A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
Date of disclosure of the study information 2014/02/22
Last modified on 2024/01/05 13:54:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer

Acronym

Phase I study of CBDCA+nab-PTX+TRT with locally advanced NSCLC

Scientific Title

A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer

Scientific Title:Acronym

Phase I study of CBDCA+nab-PTX+TRT with locally advanced NSCLC

Region

Japan


Condition

Condition

non small cell lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the recommended dose of concurrent chemoradiotherapy with Carboplatin and nab-Paclitaxel for untreated locally advanced non-small cell lung cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

Estimation of the recommended dose, evaluation of dose-limiting toxicity

Key secondary outcomes

safety and efficacy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients receive CBDCA (AUC 2) and nab-paclitaxel (35, 40, 45mg/m2) on day 1 every weeks with concurrent thoracic radiation therapy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) histologically or cytologically comfirmed non-small cell lung cancer
2) patient has an indication for concurrent chemoradiotherapy.
3) ECOG performance status of 0-2
4) patients aged 20 years or older
5) adequate bone marrow, liver, and renal functions 2weeks prior to registration:
neutorophil >=1,500/mm3; platelet >=100,000/mm3; AST and ALT < 5x of upper limit of normal (ULN); total bilirubin <=1.5mg/mL; serum creatinin <=1.5 mg/dl; SpO2>90
6) a life expectancy of 3 months or more
7) written informed consent

Key exclusion criteria

1) Patients with active lung disease such as interstitial pneumonia, pneumoconiosis, radiation pneumonitis, or drug-induced lung damage
2) complicated by infectious disease requiring intravenous administration of antifungal agents and/or antibacterial agents
3) active double cancer
4) Patients with problematic complication(s) (ex. uncontrol heart disease, serious arrhythmia)
5) pregnant or lactating women or those who declined contraception
6) Patients with severe mental illness
7) Unsuitable patients judged by the attending physician

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Akihito
Middle name
Last name Yokoyama

Organization

Kochi University, School of Medicine

Division name

Dept of Hematology and Respiratory Medicine

Zip code

783-8505

Address

Kohasu, Okocho, Nankoku city, Kochi

TEL

088-880-2345

Email

im25@kochi-u.ac.jp


Public contact

Name of contact person

1st name Tetsuya
Middle name
Last name Kubota

Organization

Kochi University, School of Medicine

Division name

Dept of Hematology and Respiratory Medicine

Zip code

783-8505

Address

Kohasu, Okocho, Nankoku city, Kochi

TEL

088-880-2345

Homepage URL


Email

kubotat@kochi-u.ac.jp


Sponsor or person

Institute

Kochi University

Institute

Department

Personal name



Funding Source

Organization

Kochi University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kochi Univeersity

Address

Kohasu,Oko-cho,Nankoku-shi,Kochi

Tel

088-880-2719

Email

im62@kochi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 22 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://iv.iiarjournals.org/content/38/1/259

Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2024 Year 01 Month 01 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 11 Month 07 Day

Date of IRB

2013 Year 11 Month 07 Day

Anticipated trial start date

2013 Year 11 Month 14 Day

Last follow-up date

2023 Year 11 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 02 Month 22 Day

Last modified on

2024 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015432


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name